ResearchKit: A software framework designed to benefit medical research
apple.com
apple.com
:)
http://thetyee.ca/Opinion/2015/02/24/Nestle-Pays-Nothing-to-...
The last estimate I saw was that Nestle was going to pay about $550/yr to bottle and sell our water back to us.
The difference with plain water is it's pretty much a true commodity product; assuming free-market economics, if it really were feasible to lower prices it would have already happened.
http://www.usatoday.com/story/money/2015/02/03/coca-cola-cok...
Medical research faces a real challenge of selection bias. Survey respondents and study participants largely come from two groups: 1) undergrads responding to a campus flyer, and 2) local university-town residents looking to make extra money. Obviously this means respondents are geographically homogenous, and in many cases socioeconomically homogenous as well. Enabling a wider reach for researchers will not only increase sample size, but also eliminate selection bias. This is a very, very good thing.
Also, now research isn't limited to only university researchers.
I wonder if the plan is to allow participants to earn credits on apple pay.
The hard thing about such sites is:how do you incentivize people to contribute really personal information and do so on a regular basis(even if said action takes a relatively long time) ?
So i wonder what can Apple do to make this activity common, that other companies couldn't do ? How will they achieve this ?
A large marketing budget helps, e.g. see the video they launched with. Making it easy to use and frictionless would also help (no need to log into the website, no need to figure out how to sign a PDF or download a consent form or whatever the normal user flow is).
What concerns me is people gaming the apps; downloading them and filling them with fake data just to be malicious. You fix one problem and introduce another...
The big step in clinical research is the PIII trial and these are almost universally held up in enrollment. If this stuff was pervasive and trusty enough to be used in even a fraction of trial therapeutic areas it would revolutionize research and medicine in those indications.
All that to suggest the opportunity. I'm not exactly bullish on Research Kit tbh though. The "if" in my first sentence still appears to be a ways out and the kind of "throw the kitchen sink at it and average everything out in post" analytics championed by big data/machine learning of today doesn't fly well with the FDA.
At least not yet.
Apple has created a UI toolkit to enable researchers to directly get data from participants via an app. All control is in the hands of the researcher creating the app.
And the app will be used for traditional research studies, the only difference is that participants enter data via their app.
I think having millions of participants in most cases is very worth having the bias that it will introduce. It'll be better than the middle class white kid bias that already exists in a lot of this research.
Of course I guess that kind of thing happens already. Just wondering will this make it worse, better or about the same.
The current crop of apps have nothing to do with rating products.
http://www.apple.com/researchkit/
The Apple Watch would likely be an ideal tool to improve prescription compliance in older patients. Perfect for issuing reminders about time and dosage (and for getting a confirmation that the task has been completed).
And that's with nominally functioning adults.
It wouldn't surprise me if that needs FDA approval.
This study uses iPads for cognitive training in patients with Schizophrenia:
http://woolleylab.ucsf.edu/forecast
Personal use of the iPad is one of the perks of participating.
Asthma Health by Mount Sinai
https://itunes.apple.com/us/app/asthma-health-by-mount-sinai...
Share the Journey by Dana-Farber Cancer Institute, Penn Medicine, UCLA’s Jonsson Comprehensive Cancer Center, and Sage Bionetworks
https://itunes.apple.com/us/app/share-the-journey/id97218060...
Parkinson mPower study app by Sage Bionetworks, University of Rochester, Beijing Institute of Geriatrics, and The Michael J. Fox Foundation for Parkinson’s Research
https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewSoftw...
GlucoSuccess by Mass General
https://itunes.apple.com/us/app/glucosuccess/id972143976?mt=...
My Heart Counts by Stanford Medicine
https://itunes.apple.com/us/app/myheart-counts/id972189947?m...
I don't know about that. HealthKit is essentially closed and no one seems to mind, and it's all about the data ultimately anyway. Maybe it's a regulatory thing? Regardless, it's nice to see.
Apps, sure. Tools? Hell no. File processors, browsers, libraries.... But HealthKit adds virtually no value aside from the schema of health data. There's not much to be gained from opening it. Honestly, I'd argue the same about hacker news and reddit: it's great that reddit is open source, but it's hardly necessary for me to perform research on it because the semantics of loading/storing/existing are so well defined.
These kinds of discussions tend to devolve into platform bickering rather than substantive commentary.
True. However, occasionally (I at least) learn something new from these conversations.
---
You know, you could name projects instead of clicking the upside-down arrow. Clang comes to mind (not LLVM). Google and others contribute heavily to clang, but Apple started it. They deserve credit for that. Anything else?
That's true of Cups and part of WebKit (most of the actual browser engine is BSD-licensed, but there are LGPL libraries used); however, Apple was certainly under no obligation to contribute its changes to LLVM back, or to contribute clang back _at all_.
License Exceptions
1. (a) Software that is developed by any person or entity for an Apple Operating System ("Apple OS-Developed Software"), including but not limited to Apple and third party printer drivers, filters, and backends for an Apple Operating System, that is linked to the CUPS imaging library or based on any sample filters or backends provided with CUPS shall not be considered to be a derivative work or collective work based on the CUPS program and is exempt from the mandatory source code release clauses of the GNU GPL.
[1] http://www.cups.org/documentation.php/doc-1.5/license.html
Also the x86 Darwin kernel was made open source with no benefit to Apple, and winocm managed to port it to ARM too (although it's pretty debatable if it actually provides anything useful)
most of the time, it's broken or need closed source dependencies.
Wonder if they announced anything about external addon biosensors?
A formal standard that can be implemented and used by other platforms, both on the device and server side, would be great. But Apple's last promise to make something they developed "open" (iMessage as a standard) evaporated and has since been completely proprietary.
As long as the data this gathers can't be used (or contributed to) by a third party, it's still a 100% Apple property, regardless of code availability.
I've worked in medical practice (and research) for a long time. Considering the vital importance of transactional transparency in carrying out the mission of these fields, as useful as open source is generally, I think the impact in medicine is even greater.
But open source is only part of it, open platform is at least as important. I guess I'm not a very trusting soul. Frankly, I don't believe Apple is going to do anything primarily for our good. Rather to my senses the announcement has the flavor of an attempt to gain a toehold or increase market share in the big money research domain.
If Apple (or other player) truly wants to generously donate to the public cause, that's wonderful. Then why not support efforts to develop open source, cross-platform apps, assuring all medical research can benefit? Not directed only or in particular at Apple, it's an issue I've raised whenever I have the chance: open source/platform agnostic development can save money and produce more reliable and secure systems.
https://developer.apple.com/researchkit/researchkit-technica...
It appears to mostly be an iOS UI toolkit of sorts for easing the creation of individual apps to collect research data. The hard work must still be done by each individual research project.
How is this better an an online polling software - like surveymonkey or polldaddy?
From reading the press release, it seems like it is a data collection software from patients. Is there more to it?
Patients can't track all this by themselves. Plus, it will automatically send it to researchers. Much easier than making someone enter information on surveymonkey or polldaddy.
We'll see.